Play Video
Dr. Matthew “Oki” O’Connor in Berlin at Undoing Aging 2019. There, he debuted the Underdog Project to the public: a novel approach to attack the leading cause of death.
Dr. Matthew “Oki” O’Connor in Berlin at Undoing Aging 2019. There, he debuted the Underdog Project to the public: a novel approach to attack the leading cause of death.
Underdog Pharmaceuticals Announces MD.USE Partnership and Technology Acquisition MOUNTAIN VIEW, Calif., Jun. 12, 2020 — Underdog Pharmaceuticals, Inc., a pharmaceutical company designing engineered cyclodextrins to address atherosclerosis and other serious diseases of aging, has completed
Scientists from Underdog Pharmaceuticals, in conjunction with Professor Jay Jerome of Vanderbilt University Medical Center, have published an article in the journal Redox Biology, covering the role of the toxic biomolecule 7-ketocholesterol, especially in the
Kizoo Technology Capital leads seed round financing at Underdog Pharmaceuticals SRF announces leadership appointments MOUNTAIN VIEW, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — Underdog Pharmaceuticals, Inc. (Underdog), and SENS Research Foundation (SRF) today announced the launch
https://www.youtube.com/watch?v=cUM7grTgjLA Dr. Matthew “Oki” O’Connor in Berlin at Undoing Aging 2019. There, he debuted the Underdog Project to the public: a novel approach to attack the leading cause of death.